Myths, Misconceptions and Myopia: Searching for Clarity in the Debate about the Regulation of Consumer Genetics | Citedby Results | Public Health Genomics | Karger Publishers

Skip to Main Content

Skip Nav Destination

Myths, Misconceptions and Myopia: Searching for Clarity in the Debate about the Regulation of Consumer Genetics

Public Health Genomics (2010) 13 (5): 322–326.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Genetics in the 21st Century: Implications for patients, consumers and citizens

Jonathan Roberts
Anna Middleton

F1000Research (2018) 6: 2020.

Regulating the Advertising and Promotion of Stem Cell Therapies

Barbara von Tigerstrom

Regenerative Medicine (2017) 12 (7): 815.

Direct-To-Consumer Genetic Testing: Where and How Does Genetic Counseling Fit?

Anna Middleton
Álvaro Mendes
Caroline M Benjamin
Heidi Carmen Howard

Personalized Medicine (2017) 14 (3): 249.

Regulatory controls for direct-to-consumer genetic tests: a case study on how the FDA exercised its authority

Margaret Curnutte

New Genetics and Society (2017) 36 (3): 209.

Genetics in the 21st Century: Implications for patients, consumers and citizens

Jonathan Roberts
Anna Middleton

F1000Research (2017) 6: 2020.

Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review

Loredana Covolo
Sara Rubinelli
Elisabetta Ceretti
Umberto Gelatti

Journal of Medical Internet Research (2015) 17 (12): e279.

Captious certainties: makings, meanings and misreadings of consumer-oriented genetic testing

Norbert W. Paul
Mita Banerjee
Susanne Michl

Journal of Community Genetics (2014) 5 (1): 81.

Ordering the Correct Genetic Test: Implications for Oncology and Primary Care Healthcare Professionals

Suzanne M. Mahon

Clinical Journal of Oncology Nursing (2013) 17 (2): 128.

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation

Paula Saukko

Proceedings of the Nutrition Society (2013) 72 (1): 53.

Direct‐to‐consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value

Rebecca Mathews
Wayne Hall
Adrian Carter

Addiction (2012) 107 (12): 2069.

DTC genetic testing companies fail transparency prescriptions

Norman P. Lewis
Debbie Treise
Stephen I. Hsu
William L. Allen
Hannah Kang

New Genetics and Society (2011) 30 (4): 291.